ID   AP4B1_HUMAN             Reviewed;         739 AA.
AC   Q9Y6B7; B7Z4X3; Q59EJ4; Q96CL6;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   20-FEB-2007, sequence version 2.
DT   18-JUN-2025, entry version 195.
DE   RecName: Full=AP-4 complex subunit beta-1 {ECO:0000305};
DE   AltName: Full=AP-4 adaptor complex subunit beta;
DE   AltName: Full=Adaptor-related protein complex 4 subunit beta-1;
DE   AltName: Full=Beta subunit of AP-4;
DE   AltName: Full=Beta4-adaptin;
GN   Name=AP4B1 {ECO:0000312|HGNC:HGNC:572};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBUNIT, SUBCELLULAR
RP   LOCATION, TOPOLOGY, AND VARIANT SER-480.
RC   TISSUE=Skeletal muscle;
RX   PubMed=10066790; DOI=10.1074/jbc.274.11.7278;
RA   Dell'Angelica E.C., Mullins C., Bonifacino J.S.;
RT   "AP-4, a novel protein complex related to clathrin adaptors.";
RL   J. Biol. Chem. 274:7278-7285(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Lung;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT SER-480.
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=10436028; DOI=10.1091/mbc.10.8.2787;
RA   Hirst J., Bright N.A., Rous B., Robinson M.S.;
RT   "Characterization of a fourth adaptor-related protein complex.";
RL   Mol. Biol. Cell 10:2787-2802(1999).
RN   [7]
RP   INVOLVEMENT IN SPG47.
RX   PubMed=21620353; DOI=10.1016/j.ajhg.2011.04.019;
RA   Abou Jamra R., Philippe O., Raas-Rothschild A., Eck S.H., Graf E.,
RA   Buchert R., Borck G., Ekici A., Brockschmidt F.F., Nothen M.M., Munnich A.,
RA   Strom T.M., Reis A., Colleaux L.;
RT   "Adaptor protein complex 4 deficiency causes severe autosomal-recessive
RT   intellectual disability, progressive spastic paraplegia, shy character, and
RT   short stature.";
RL   Am. J. Hum. Genet. 88:788-795(2011).
RN   [8]
RP   INTERACTION WITH TEPSIN, AND SUBCELLULAR LOCATION.
RX   PubMed=22472443; DOI=10.1083/jcb.201111049;
RA   Borner G.H., Antrobus R., Hirst J., Bhumbra G.S., Kozik P., Jackson L.P.,
RA   Sahlender D.A., Robinson M.S.;
RT   "Multivariate proteomic profiling identifies novel accessory proteins of
RT   coated vesicles.";
RL   J. Cell Biol. 197:141-160(2012).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   INTERACTION WITH TEPSIN, REGION, AND MUTAGENESIS OF TRP-635 AND TYR-682.
RX   PubMed=26542808; DOI=10.1074/jbc.m115.683409;
RA   Mattera R., Guardia C.M., Sidhu S.S., Bonifacino J.S.;
RT   "Bivalent motif-ear interactions mediate the association of the accessory
RT   protein tepsin with the AP-4 adaptor complex.";
RL   J. Biol. Chem. 290:30736-30749(2015).
RN   [11]
RP   INTERACTION WITH TEPSIN, AND MUTAGENESIS OF ILE-669; ALA-670 AND TYR-682.
RX   PubMed=26756312; DOI=10.1111/tra.12375;
RA   Frazier M.N., Davies A.K., Voehler M., Kendall A.K., Borner G.H.,
RA   Chazin W.J., Robinson M.S., Jackson L.P.;
RT   "Molecular basis for the interaction between AP4 beta4 and its accessory
RT   protein, tepsin.";
RL   Traffic 17:400-415(2016).
RN   [12]
RP   STRUCTURE BY NMR OF 610-739.
RG   Northeast structural genomics consortium (NESG);
RT   "Solution NMR structure of beta-adaptin appendage domain of human adapter
RT   protein complex 4 subunit beta, Northeast structural genomics consortium
RT   (NESG) target HR8998C.";
RL   Submitted (JAN-2014) to the PDB data bank.
CC   -!- FUNCTION: Component of the adaptor protein complex 4 (AP-4). Adaptor
CC       protein complexes are vesicle coat components involved both in vesicle
CC       formation and cargo selection. They control the vesicular transport of
CC       proteins in different trafficking pathways (PubMed:10066790,
CC       PubMed:10436028). AP-4 forms a non clathrin-associated coat on vesicles
CC       departing the trans-Golgi network (TGN) and may be involved in the
CC       targeting of proteins from the trans-Golgi network (TGN) to the
CC       endosomal-lysosomal system. It is also involved in protein sorting to
CC       the basolateral membrane in epithelial cells and the proper asymmetric
CC       localization of somatodendritic proteins in neurons. AP-4 is involved
CC       in the recognition and binding of tyrosine-based sorting signals found
CC       in the cytoplasmic part of cargos, but may also recognize other types
CC       of sorting signal (Probable). {ECO:0000269|PubMed:10066790,
CC       ECO:0000269|PubMed:10436028, ECO:0000305|PubMed:10066790,
CC       ECO:0000305|PubMed:10436028}.
CC   -!- SUBUNIT: Adaptor protein complex 4 (AP-4) is a heterotetramer composed
CC       of two large adaptins (epsilon-type subunit AP4E1 and beta-type subunit
CC       AP4B1), a medium adaptin (mu-type subunit AP4M1) and a small adaptin
CC       (sigma-type AP4S1) (PubMed:10066790, PubMed:10436028). Interacts with
CC       TEPSIN; this interaction requires the presence of a functional AP-4
CC       complex (PubMed:22472443, PubMed:26542808, PubMed:26756312). Interacts
CC       with GRIA2; probably indirect it mediates the somatodendritic
CC       localization of GRIA2 in neurons (By similarity).
CC       {ECO:0000250|UniProtKB:Q9WV76, ECO:0000269|PubMed:10066790,
CC       ECO:0000269|PubMed:10436028, ECO:0000269|PubMed:22472443,
CC       ECO:0000269|PubMed:26542808, ECO:0000269|PubMed:26756312}.
CC   -!- INTERACTION:
CC       Q9Y6B7; Q96N21: TEPSIN; NbExp=8; IntAct=EBI-1047606, EBI-11139477;
CC       Q9Y6B7; Q9H609: ZNF576; NbExp=7; IntAct=EBI-1047606, EBI-3921014;
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus, trans-Golgi network membrane
CC       {ECO:0000269|PubMed:10066790, ECO:0000269|PubMed:10436028,
CC       ECO:0000269|PubMed:22472443}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:10066790}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9Y6B7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y6B7-2; Sequence=VSP_055787, VSP_055788, VSP_055789;
CC   -!- TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:10436028}.
CC   -!- DISEASE: Spastic paraplegia 47, autosomal recessive (SPG47)
CC       [MIM:614066]: A form of spastic paraplegia, a neurodegenerative
CC       disorder characterized by a slow, gradual, progressive weakness and
CC       spasticity of the lower limbs. SPG47 is characterized by neonatal
CC       hypotonia that progresses to hypertonia and spasticity, and severe
CC       intellectual disability with poor or absent speech development.
CC       {ECO:0000269|PubMed:21620353}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the adaptor complexes large subunit family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD93054.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF092094; AAD20448.1; -; mRNA.
DR   EMBL; AK298037; BAH12709.1; -; mRNA.
DR   EMBL; AB209817; BAD93054.1; ALT_INIT; mRNA.
DR   EMBL; AL137856; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC014146; AAH14146.1; -; mRNA.
DR   CCDS; CCDS865.1; -. [Q9Y6B7-1]
DR   RefSeq; NP_001240781.1; NM_001253852.3. [Q9Y6B7-1]
DR   RefSeq; NP_001240782.1; NM_001253853.2.
DR   RefSeq; NP_001295241.1; NM_001308312.1.
DR   RefSeq; NP_006585.2; NM_006594.5. [Q9Y6B7-1]
DR   RefSeq; XP_047294803.1; XM_047438847.1. [Q9Y6B7-1]
DR   RefSeq; XP_054189884.1; XM_054333909.1. [Q9Y6B7-1]
DR   PDB; 2MJ7; NMR; -; A=610-739.
DR   PDBsum; 2MJ7; -.
DR   AlphaFoldDB; Q9Y6B7; -.
DR   SMR; Q9Y6B7; -.
DR   BioGRID; 115943; 24.
DR   ComplexPortal; CPX-5151; AP-4 Adaptor complex.
DR   CORUM; Q9Y6B7; -.
DR   DIP; DIP-24209N; -.
DR   FunCoup; Q9Y6B7; 1277.
DR   IntAct; Q9Y6B7; 19.
DR   STRING; 9606.ENSP00000358582; -.
DR   TCDB; 9.B.278.1.5; the organellar-targeting adaptor protein complex (o-apc) family.
DR   iPTMnet; Q9Y6B7; -.
DR   PhosphoSitePlus; Q9Y6B7; -.
DR   BioMuta; AP4B1; -.
DR   DMDM; 126302520; -.
DR   jPOST; Q9Y6B7; -.
DR   MassIVE; Q9Y6B7; -.
DR   PaxDb; 9606-ENSP00000358582; -.
DR   PeptideAtlas; Q9Y6B7; -.
DR   ProteomicsDB; 6643; -.
DR   ProteomicsDB; 86647; -. [Q9Y6B7-1]
DR   Pumba; Q9Y6B7; -.
DR   Antibodypedia; 33851; 153 antibodies from 23 providers.
DR   DNASU; 10717; -.
DR   Ensembl; ENST00000256658.8; ENSP00000256658.4; ENSG00000134262.15. [Q9Y6B7-1]
DR   Ensembl; ENST00000369569.6; ENSP00000358582.1; ENSG00000134262.15. [Q9Y6B7-1]
DR   Ensembl; ENST00000369571.3; ENSP00000358584.3; ENSG00000134262.15. [Q9Y6B7-1]
DR   Ensembl; ENST00000713590.1; ENSP00000518886.1; ENSG00000134262.15. [Q9Y6B7-1]
DR   Ensembl; ENST00000713645.1; ENSP00000518947.1; ENSG00000134262.15. [Q9Y6B7-1]
DR   GeneID; 10717; -.
DR   KEGG; hsa:10717; -.
DR   MANE-Select; ENST00000369569.6; ENSP00000358582.1; NM_001253852.3; NP_001240781.1.
DR   UCSC; uc001eeb.4; human. [Q9Y6B7-1]
DR   AGR; HGNC:572; -.
DR   CTD; 10717; -.
DR   DisGeNET; 10717; -.
DR   GeneCards; AP4B1; -.
DR   GeneReviews; AP4B1; -.
DR   HGNC; HGNC:572; AP4B1.
DR   HPA; ENSG00000134262; Low tissue specificity.
DR   MalaCards; AP4B1; -.
DR   MIM; 607245; gene.
DR   MIM; 614066; phenotype.
DR   OpenTargets; ENSG00000134262; -.
DR   Orphanet; 280763; Severe intellectual disability and progressive spastic paraplegia.
DR   VEuPathDB; HostDB:ENSG00000134262; -.
DR   eggNOG; KOG1061; Eukaryota.
DR   GeneTree; ENSGT00940000157025; -.
DR   HOGENOM; CLU_006320_4_2_1; -.
DR   InParanoid; Q9Y6B7; -.
DR   OMA; FIQRPTR; -.
DR   OrthoDB; 10254310at2759; -.
DR   PAN-GO; Q9Y6B7; 1 GO annotation based on evolutionary models.
DR   PhylomeDB; Q9Y6B7; -.
DR   PathwayCommons; Q9Y6B7; -.
DR   Reactome; R-HSA-432720; Lysosome Vesicle Biogenesis.
DR   Reactome; R-HSA-432722; Golgi Associated Vesicle Biogenesis.
DR   SignaLink; Q9Y6B7; -.
DR   BioGRID-ORCS; 10717; 20 hits in 1163 CRISPR screens.
DR   GeneWiki; AP4B1; -.
DR   GenomeRNAi; 10717; -.
DR   Pharos; Q9Y6B7; Tbio.
DR   PRO; PR:Q9Y6B7; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q9Y6B7; protein.
DR   Bgee; ENSG00000134262; Expressed in granulocyte and 188 other cell types or tissues.
DR   ExpressionAtlas; Q9Y6B7; baseline and differential.
DR   GO; GO:0030124; C:AP-4 adaptor complex; IDA:UniProtKB.
DR   GO; GO:0030131; C:clathrin adaptor complex; IEA:InterPro.
DR   GO; GO:0098541; C:cytoplasmic side of trans-Golgi network transport vesicle membrane; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0031904; C:endosome lumen; TAS:Reactome.
DR   GO; GO:0005802; C:trans-Golgi network; IDA:UniProtKB.
DR   GO; GO:0032588; C:trans-Golgi network membrane; TAS:Reactome.
DR   GO; GO:0030276; F:clathrin binding; IEA:InterPro.
DR   GO; GO:0006886; P:intracellular protein transport; IEA:InterPro.
DR   GO; GO:0008104; P:protein localization; IC:UniProtKB.
DR   GO; GO:0061938; P:protein localization to somatodendritic compartment; IEA:Ensembl.
DR   GO; GO:0006605; P:protein targeting; IC:UniProtKB.
DR   GO; GO:0016192; P:vesicle-mediated transport; NAS:ComplexPortal.
DR   FunFam; 1.25.10.10:FF:000151; AP complex subunit beta; 1.
DR   FunFam; 3.30.310.10:FF:000013; AP complex subunit beta; 1.
DR   Gene3D; 1.25.10.10; Leucine-rich Repeat Variant; 1.
DR   Gene3D; 3.30.310.10; TATA-Binding Protein; 1.
DR   InterPro; IPR026739; AP_beta.
DR   InterPro; IPR016342; AP_complex_bsu_1_2_4.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR015151; B-adaptin_app_sub_C.
DR   InterPro; IPR002553; Clathrin/coatomer_adapt-like_N.
DR   InterPro; IPR012295; TBP_dom_sf.
DR   PANTHER; PTHR11134; ADAPTOR COMPLEX SUBUNIT BETA FAMILY MEMBER; 1.
DR   Pfam; PF01602; Adaptin_N; 1.
DR   Pfam; PF09066; B2-adapt-app_C; 1.
DR   PIRSF; PIRSF002291; AP_complex_beta; 1.
DR   SMART; SM01020; B2-adapt-app_C; 1.
DR   SUPFAM; SSF48371; ARM repeat; 1.
DR   neXtProt; NX_Q9Y6B7; -.
DR   PharmGKB; PA24864; -.
DR   TreeFam; TF354235; -.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Golgi apparatus;
KW   Hereditary spastic paraplegia; Membrane; Neurodegeneration;
KW   Protein transport; Proteomics identification; Reference proteome;
KW   Transport.
FT   CHAIN           1..739
FT                   /note="AP-4 complex subunit beta-1"
FT                   /id="PRO_0000193750"
FT   REGION          534..600
FT                   /note="Hinge"
FT                   /evidence="ECO:0000305|PubMed:26542808"
FT   REGION          601..739
FT                   /note="Ear; mediates interaction with TEPSIN"
FT                   /evidence="ECO:0000269|PubMed:26542808"
FT   VAR_SEQ         113..205
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055787"
FT   VAR_SEQ         373..395
FT                   /note="GIARTYTDQCVQILTELLGLRQE -> RCLLLFLLENLDQPARKLWLEEP
FT                   (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055788"
FT   VAR_SEQ         396..739
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055789"
FT   VARIANT         480
FT                   /note="L -> S (in dbSNP:rs1217401)"
FT                   /evidence="ECO:0000269|PubMed:10066790, ECO:0000269|Ref.3"
FT                   /id="VAR_030804"
FT   MUTAGEN         635
FT                   /note="W->A: Decreased interaction with TEPSIN."
FT                   /evidence="ECO:0000269|PubMed:26542808"
FT   MUTAGEN         669
FT                   /note="I->A: Decreased interaction with TEPSIN; when
FT                   associated with S-670."
FT                   /evidence="ECO:0000269|PubMed:26756312"
FT   MUTAGEN         670
FT                   /note="A->S: Decreased interaction with TEPSIN; when
FT                   associated with A-669."
FT                   /evidence="ECO:0000269|PubMed:26756312"
FT   MUTAGEN         682
FT                   /note="Y->A,V: Decreased interaction with TEPSIN."
FT                   /evidence="ECO:0000269|PubMed:26542808,
FT                   ECO:0000269|PubMed:26756312"
FT   CONFLICT        140
FT                   /note="A -> V (in Ref. 1; AAD20448)"
FT                   /evidence="ECO:0000305"
FT   HELIX           628..637
FT                   /evidence="ECO:0007829|PDB:2MJ7"
FT   STRAND          641..647
FT                   /evidence="ECO:0007829|PDB:2MJ7"
FT   HELIX           654..663
FT                   /evidence="ECO:0007829|PDB:2MJ7"
FT   STRAND          667..671
FT                   /evidence="ECO:0007829|PDB:2MJ7"
FT   STRAND          677..687
FT                   /evidence="ECO:0007829|PDB:2MJ7"
FT   STRAND          692..699
FT                   /evidence="ECO:0007829|PDB:2MJ7"
FT   STRAND          701..703
FT                   /evidence="ECO:0007829|PDB:2MJ7"
FT   STRAND          705..714
FT                   /evidence="ECO:0007829|PDB:2MJ7"
FT   HELIX           717..735
FT                   /evidence="ECO:0007829|PDB:2MJ7"
SQ   SEQUENCE   739 AA;  83260 MW;  B6FC92215BDA5EDC CRC64;
     MPYLGSEDVV KELKKALCNP HIQADRLRYR NVIQRVIRYM TQGLDMSGVF MEMVKASATV
     DIVQKKLVYL YMCTYAPLKP DLALLAINTL CKDCSDPNPM VRGLALRSMC SLRMPGVQEY
     IQQPILNGLR DKASYVRRVA VLGCAKMHNL HGDSEVDGAL VNELYSLLRD QDPIVVVNCL
     RSLEEILKQE GGVVINKPIA HHLLNRMSKL DQWGQAEVLN FLLRYQPRSE EELFDILNLL
     DSFLKSSSPG VVMGATKLFL ILAKMFPHVQ TDVLVRVKGP LLAACSSESR ELCFVALCHV
     RQILHSLPGH FSSHYKKFFC SYSEPHYIKL QKVEVLCELV NDENVQQVLE ELRGYCTDVS
     ADFAQAAIFA IGGIARTYTD QCVQILTELL GLRQEHITTV VVQTFRDLVW LCPQCTEAVC
     QALPGCEENI QDSEGKQALI WLLGVHGERI PNAPYVLEDF VENVKSETFP AVKMELLTAL
     LRLFLSRPAE CQDMLGRLLY YCIEEEKDMA VRDRGLFYYR LLLVGIDEVK RILCSPKSDP
     TLGLLEDPAE RPVNSWASDF NTLVPVYGKA HWATISKCQG AERCDPELPK TSSFAASGPL
     IPEENKERVQ ELPDSGALML VPNRQLTADY FEKTWLSLKV AHQQVLPWRG EFHPDTLQMA
     LQVVNIQTIA MSRAGSRPWK AYLSAQDDTG CLFLTELLLE PGNSEMQISV KQNEARTETL
     NSFISVLETV IGTIEEIKS
//
